Ciprofloxacin in urinary tract infections

N Høiby

Ciprofloxacin in urinary tract infections

6 Citationer (Scopus)

Abstract

The high in vitro activity of ciprofloxacin against most urinary tract pathogens and its favourable pharmacokinetics suggests considerable potential for use in therapy. The published controlled clinical trials show that ciprofloxacin has few adverse reactions and is at least as effective as the drugs with which it was compared.

Originalsprog	Engelsk
Bogserie	Scandinavian Journal of Infectious Diseases. Supplementum
Vol/bind	60
Sider (fra-til)	54-7
Antal sider	4
ISSN	0300-8878
Status	Udgivet - 1989
Udgivet eksternt	Ja

Andre filer og links

Link to publication in Scopus

Citationsformater

@article{aa73be0ed784411baabee116a85f4fce,

title = "Ciprofloxacin in urinary tract infections",

abstract = "The high in vitro activity of ciprofloxacin against most urinary tract pathogens and its favourable pharmacokinetics suggests considerable potential for use in therapy. The published controlled clinical trials show that ciprofloxacin has few adverse reactions and is at least as effective as the drugs with which it was compared.",

keywords = "Bacteria/isolation \& purification, Ciprofloxacin/therapeutic use, Clinical Trials as Topic, Costs and Cost Analysis, Female, Humans, Male, Urinary Tract Infections/drug therapy",

author = "N H{\o}iby",

year = "1989",

language = "English",

volume = "60",

pages = "54--7",

journal = "Scandinavian Journal of Infectious Diseases. Supplementum",

issn = "0300-8878",

publisher = "Taylor and Francis Ltd.",

}

TY - JOUR

T1 - Ciprofloxacin in urinary tract infections

AU - Høiby, N

PY - 1989

Y1 - 1989

N2 - The high in vitro activity of ciprofloxacin against most urinary tract pathogens and its favourable pharmacokinetics suggests considerable potential for use in therapy. The published controlled clinical trials show that ciprofloxacin has few adverse reactions and is at least as effective as the drugs with which it was compared.

AB - The high in vitro activity of ciprofloxacin against most urinary tract pathogens and its favourable pharmacokinetics suggests considerable potential for use in therapy. The published controlled clinical trials show that ciprofloxacin has few adverse reactions and is at least as effective as the drugs with which it was compared.

KW - Bacteria/isolation & purification

KW - Ciprofloxacin/therapeutic use

KW - Clinical Trials as Topic

KW - Costs and Cost Analysis

KW - Female

KW - Humans

KW - Male

KW - Urinary Tract Infections/drug therapy

UR - https://www.scopus.com/pages/publications/0024387468

M3 - Journal article

C2 - 2667108

SN - 0300-8878

VL - 60

SP - 54

EP - 57

JO - Scandinavian Journal of Infectious Diseases. Supplementum

JF - Scandinavian Journal of Infectious Diseases. Supplementum

ER -

Ciprofloxacin in urinary tract infections

Abstract

Andre filer og links

Fingeraftryk

Citationsformater